Peter Seeberger

Managing Director, Max-Planck Institute Colloids and Interfaces

With a focus on creating novel vaccines, Peter aims to help protect patients against infectious diseases and improve the accessibility of drugs. “New technologies such as continuous manufacturing to produce known drugs and vaccines will make them affordable to broader parts of the world’s population.”

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019